A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.
Oct 18, 2023
0
24
Live vaccinations provided to children who previously received liver or kidney transplants were found to be safe and prompted an immune response to guard against several life-threatening conditions, according to a new study ...
Oct 16, 2023
0
9
Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among people worldwide living with HIV.
Oct 10, 2023
0
23
Building on a new mathematical model that represents vaccine hesitancy as a belief that can influence whether parents vaccinate their children, Nicole Creanza, assistant professor of biological sciences, and postdoctoral ...
Oct 6, 2023
1
32
A person's immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure—and differences in the focus of immune responses will help scientists understand how to optimize vaccines ...
Oct 5, 2023
1
9
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Oct 5, 2023
0
16
What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in health care settings?
Oct 4, 2023
0
32
Messenger RNA (mRNA) technology has become popular in the last few years due to its use in COVID-19 vaccines. This technology has been so groundbreaking that it recently won the 2023 Nobel Prize in medicine "for discoveries ...
Oct 3, 2023
0
26
Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.
Oct 2, 2023
0
31
Researchers at Karolinska Institutet who studied SARS-CoV-2 variant BA.2.86, found that the new variant was not significantly more resistant to antibodies than several other variants that are circulating. The study also showed ...
Oct 2, 2023
0
30
